Switch to:
More From Other Websites
4 IBD 50 Drugmakers Getting Lift From New Treatments Aug 29 2015
Gilead & Amgen Account for Nearly 75% of the Biotech Profit Pool Aug 28 2015
Amgen v. Regeneron: Everyone Wins? Aug 28 2015
Time to Buy Amgen After Newly Approved Drug? Aug 28 2015
Amgen wins approval for second biotech cholesterol drug Aug 27 2015
Amgen wins approval for second biotech cholesterol drug Aug 27 2015
Amgen's Repatha OK'd With Similar Label To Praluent Aug 27 2015
FDA approves Amgen's cholesterol drug Repatha Aug 27 2015
Cholesterol drug wars Aug 27 2015
Regeneron Pharmaceuticals (REGN) Stock Is the 'Chart of the Day' Aug 27 2015
'We See Opportunity in Biogen, Gilead and Regeneron,' Morgan Stanley Says Aug 27 2015
Cholesterol drug wars: Amgen Aug 27 2015
Stocks: Don't Kill Your Darlings Aug 25 2015
9 Stocks Strong Enough To Weather This Storm Aug 25 2015
IBB ETF Pounded by Biotech and Pharma Subgroups in Early August Aug 25 2015
What Are IBB and XBI’s Valuations? Aug 25 2015
4 Stocks to Sell Now, Until the Fed Acts Aug 25 2015
A Buying Opportunity For Regeneron: RBC Aug 24 2015
4 Reasons To Keep An Eye On Biotech Stock Celgene Aug 21 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK